These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7292214)

  • 1. In vitro activity of clindamycin against Chlamydia trachomatis.
    Bowie WR
    Sex Transm Dis; 1981; 8(3):220-1. PubMed ID: 7292214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
    Walsh M; Kappus EW; Quinn TC
    Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergy of clindamycin and aminoglycosides against Chlamydia trachomatis.
    Pearlman MD; Faro S; Riddle GD; Tortolero G
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1399-401. PubMed ID: 2386371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women.
    Harrison HR; Riggin RM; Alexander ER; Weinstein L
    Am J Obstet Gynecol; 1984 Jul; 149(5):477-80. PubMed ID: 6742014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of rosaramicin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1980 Dec; 18(6):978-9. PubMed ID: 7235684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritis.
    Bowie WR; Yu JS; Jones HD
    Sex Transm Dis; 1986; 13(2):76-80. PubMed ID: 3520885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination.
    Christensen JJ; Holten-Andersen W; Nielsen PB
    Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):329-32. PubMed ID: 3788573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis.
    Martin DH; Pastorek JG; Faro S
    Sex Transm Dis; 1986; 13(2):81-7. PubMed ID: 3520886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative resistance to erythromycin in Chlamydia trachomatis.
    Mourad A; Sweet RL; Sugg N; Schachter J
    Antimicrob Agents Chemother; 1980 Nov; 18(5):696-8. PubMed ID: 7447426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.
    Bowie WR; Lee CK; Alexander ER
    J Infect Dis; 1978 Nov; 138(5):655-9. PubMed ID: 712119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.
    Jones RB; Ridgway GL; Boulding S; Hunley KL
    Rev Infect Dis; 1983; 5 Suppl 3():S556-61. PubMed ID: 6635445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
    Catalan F; Milovanovic A; Prouteau C; Soulignac M
    Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
    Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
    J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in-vitro investigation of synergy and antagonism between antimicrobials against Chlamydia trachomatis.
    How SJ; Hobson D; Hart CA; Webster RE
    J Antimicrob Chemother; 1985 May; 15(5):533-8. PubMed ID: 4008386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of dirithromycin against Chlamydia pneumoniae.
    Roblin PM; Kutlin A; Sokolovskaya N; Hammerschlag MR
    J Antimicrob Chemother; 1997 May; 39(5):647-9. PubMed ID: 9184366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.
    Ridgway GL; Owen JM; Oriel JD
    Br J Vener Dis; 1978 Apr; 54(2):103-6. PubMed ID: 638716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.